Company / Shareholders' Equity
HARROW, INC. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$52.4M
FY2025
5-year range
$11.3M / $70.8M
FY2021-FY2025
Trend
-24.7%
vs FY2024
Sector context
#182 of 213
Health Care
What the data says
HARROW, INC.'s shareholders' equity of $52M is lower than 85% of companies in the Health Care sector (FY2025). Shareholders' Equity has fluctuated over the past 10 years, ranging from -$1M in FY2016 to $71M in FY2023.
Based on SEC 10-K filings.
$52M in FY2025 with a 5-year CAGR of +14.0%.
Declined from $71M to $52M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +23.9%
- 5-Year CAGR
- +14.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 213This company $52.4M Sector average $2.5B
▼
-97.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +14.0%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 24.7% year-over-year.
- Ranks #182 out of 213 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.86 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $52.4M | -24.7% |
| FY2024 | $69.7M | -1.6% |
| FY2023 | $70.8M | +156.4% |
| FY2022 | $27.6M | +144.5% |
| FY2021 | $11.3M | -58.5% |
| FY2020 | $27.2M | -1.9% |
| FY2019 | $27.7M | +12.0% |
| FY2018 | $24.8M | +846.5% |
| FY2017 | $2.6M | +288.8% |
| FY2016 | -$1.4M | -117.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026